Urography Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Gadolinium-Based-Contrast-Agents (GBCA) Enhancement During MR Urography
Condition:   Magnetic Resonance Imaging Contrast Agents Interventions:   Drug: Magnevist;   Drug: Dotarem;   Drug: Gadovist Sponsors:   Vanderbilt University Medical Center;   Guerbet;   Children's Hospital of Philadelphia Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2019 Category: Research Source Type: clinical trials